December 2016

Review Article 
Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients
Naoki Hosen, Tetsuo Maeda, Yoshiko Hashii, Akihiro Tsuboi, Sumiyuki Nishida, Jun Nakata, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Stem Cell Investigation  
2016,  
3:
90  
Short Report 
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial
Nicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, Per Thor Straten, Inge Marie Svane, Mads Hald Andersen, Lene Meldgaard Knudsen
Stem Cell Investigation  
2016,  
3:
95  
Perspective 
The silver lining of induced pluripotent stem cell variation
Valentina Fossati, Tanya Jain, Ana Sevilla
Stem Cell Investigation  
2016,  
3:
86  
Perspective 
Outside the brain: an inside view on transgenic animal and stem cell-based models to examine neuronal serotonin-dependent regulation of HPA axis-controlled events during development and adult stages
Jonas Waider, Janina Ziegler, Thorsten Lau
Stem Cell Investigation  
2016,  
3:
94  
Editorial 
Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts
Hiroyuki Yamakawa, Keiichi Fukuda
Stem Cell Investigation  
2016,  
3:
89  
Editorial 
Cell sources for regenerative medicine of the liver and endoderm organs: strategies and perspectives
Guido Carpino, Eugenio Gaudio
Stem Cell Investigation  
2016,  
3:
91  
Commentary 
Blocking TGF-β and BMP SMAD-dependent cell differentiation is a master key to expand all kinds of epithelial stem cells
Boris Guyot, Véronique Maguer-Satta
Stem Cell Investigation  
2016,  
3:
88  
Commentary 
Novel methods for the treatment of liver fibrosis using in vivo direct reprogramming technology
Takeshi Goya, Atsushi Suzuki
Stem Cell Investigation  
2016,  
3:
92  
Commentary 
Combining retinoic acid and oral arsenic may be potentially the first-line therapy for non-high-risk acute promyelocytic leukemia
Lin Fu, Jinlong Shi, Jia Liu, Anqi Liu, Kailin Xu, Xiaoyan Ke
Stem Cell Investigation  
2016,  
3:
93  
Commentary 
Increased vulnerability of photoreceptors to aberrant splicing highlight the utility of AON-based therapy for CEP290-LCA
Shannon E. Boye
Stem Cell Investigation  
2016,  
3:
96  
Case Report 
Bone marrow derived stem cell therapy for type 2 diabetes mellitus
Tarek Wehbe, Nassim Abi Chahine, Salam Sissi, Isabelle Abou-Joaude, Louis Chalhoub
Stem Cell Investigation  
2016,  
3:
87